Australia's most trusted
source of pharma news
Thursday, 25 June 2026
Thursday, 25 June 2026
Subscribe
Login
Arrotex inks first-to-market deal
Arrotex has lost its CEO but the deals keep coming with an exclusive agreement to bring a first-to-market therapy to Australia, this time with group CEO Dennis Bastas doing the talking.
Pharma joins Ebola fight
Companies step up efforts to battle the deadly disease with WHO announcing two drugs will be trialled from next week
TODAY
Lilly says 'No' to Aussie drug launch
This new drug will not reach Aust in the foreseeable future as Lilly continues its stance against the nation's reimbursement system
TODAY
Another Country Leader departs
After just seven months in the top job and less than a year since resigning from his previous role, this ANZ leader is moving on
24 June
Second ANZ Leader resigns in 24 hours
A local GM has decided to seek other opportunities rather than take up an expanded role in a restructured company
24 June
Burnout stories from the frontline
Australian pharma professionals have lifted the lid on workload and burnout within companies with an expert revealing how to lighten the load
24 June
Which Aussie Drs love seeing Reps?
Survey reveals which healthcare practitioners most prefer to get medical information from pharma reps, and by how much
23 June
Latest Jobs
Territory Manager - SterilisationWarehouse AssistantPharmacy AssistantLoan Kit TechnicianFinance Business PartnerHR ConsultantRegulatory Affairs ManagerHead of Access, Sustainability & External Engagement35 more...
Pharma in Focus Jobs
Marketing & Communications (2)
Sales & Customer Relations (18)
- Territory Manager - Sterilisation - Melbourne
- Customer Service Representative - Sydney
- Customer Service Representative - Victoria - Mulgrave
- Territory Manager - Auckland
- Customer Service Representative - Perth
- Senior Sales Manager - Sydney
- Clinical Account Manager - Melbourne
- Account Manager - Sydney
- Territory Manager - Sydney
- Pharmaceutical Sales Representative - Brisbane
- Customer Service Representative - Macquarie Park
- Customer Service Representative - Macquarie Park
- Senior Director, Business Development - Clinical Research (Tokyo Based) - Tokyo, Japan
- Senior Director, Business Development - Clinical Research - Tokyo, Japan
- Equipment Sales Specialist - Dental - Sydney
- Territory Manager - Melbourne
- Key Account Manager - Melbourne
- Senior Group Financial Accountant - Victoria
Access & Reimbursement (2)
- Head of Access, Sustainability & External Engagement - Melbourne
- Associate Director / Senior Manager, Market Access (ANZ) - Melbourne
Clinical & Medical, R&D (7)
- Medical Reception - West Perth
- Clinical Account Manager - Melbourne
- Senior Medical Science Liaison - Sydney
- Associate Director, Clinical Operations (Japan) - Tokyo, Japan
- Senior Director, Business Development - Clinical Research (Tokyo Based) - Tokyo, Japan
- Senior Director, Business Development - Clinical Research - Tokyo, Japan
- Clinical Trial Investigator - Melbourne
Regulatory, Pharmacovigilance & QA (6)
- Regulatory Affairs Manager - Belrose
- Senior Quality Assurance Associate - Randwick
- Country Head, Regulatory Affairs, ANZ - Melbourne
- Senior Quality Assurance Manager - Sydney
- Quality Control Systems Specialist - Tullamarine
- Director - Regulatory Affairs - Melbourne
Executive Roles (5)
- Associate Director / Senior Manager, Market Access (ANZ) - Melbourne
- Associate Director, Clinical Operations (Japan) - Tokyo, Japan
- Senior Director, Business Development - Clinical Research (Tokyo Based) - Tokyo, Japan
- Director - Regulatory Affairs - Melbourne
- Senior Director, Business Development - Clinical Research - Tokyo, Japan
Other (12)
- Warehouse Assistant - Macquarie Park
- Pharmacy Assistant - Toongabbie
- Loan Kit Technician - Macquarie Park
- Finance Business Partner - North Ryde
- HR Consultant - Melbourne
- Senior SFE Analyst - Sydney
- Web Producer - Sydney
- Manufacturing Process Engineer - Blacktown
- Lab Technician - Victoria
- Senior Recruitment Consultant - Victoria
- QC Analyst - Microbiology - Melbourne
- Talent Acquisition Coordinator - Mascot
Companies eye monster market
With a trump card in the form of a superior safety profile, this partnership is ready to crack a lucrative market
TODAY
Aussie drug heads to LA
A promising new cancer treatment developed by Aussie researchers has been acquired for an undisclosed price
TODAY
July PBS wait list swells to 18
Eighteen submissions recommended by the PBAC have progressed to the final stage ahead of a possible PBS listing next month
24 June
Dept preps for more broad listings
Govt issues guidelines for pharmas wanting to win a broad listing for their anti-cancer drug but there's a catch with pricing
24 June
AbbVie pays big for major market
Pharma drops $15.6 billion for a challenger to Dupixent in atopic dermatitis, which it hopes will become a mega-blockbuster
24 June
Mega pays are not just for CEOs
You don't have to be CEO to earn a whopper salary - 10 scientists and doctors in Big Pharma have hit the jackpot with earnings of more than $AU14M last year
23 June
ASCO Breakthrough hits Singapore
Conference kicks off in Singapore for the first time with
oncologists exploring region-focused treatments, and how to expand personalisation
23 June
Company beefs up Access role
With market access an ever-growing pain point for industry, one company has broadened this function. See who's leading the new team
23 June
Funding failures hurt productivity
MA report highlights the ripple effect of delayed access to innovative medicines, extending far beyond health outcomes
23 June
Another pharma cuts Aussie jobs
Yet another Big Pharma has downsized its Australian workforce as part of a global restructure designed to realign resources
22 June
Novo hit with $105M ransom demand
The company's biggest secrets - including "confidential recipes" for its top drugs appear to be for sale on the Dark Web after the company refused hackers' demands
22 June
Industry body unveils new name
Entering its second decade, this well-known industry body has announced new branding, including a 'bold' new name
22 June
Price moves get mixed PBAC result
The PBAC agreed with two price adjustments and knocked back a third at its May Intracycle meeting. See who missed out
22 June
Pfizer's $53M drug under threat
TGA approves first generic of this big earning drug as well as a medicine accepted for review more than two years ago
22 June Approvals Action